Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rallybio Corporation - Common Stock (NQ:RLYB)

17.19 +0.03 (+0.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,092
Open 17.16
Bid (Size) 16.65 (100)
Ask (Size) 17.25 (800)
Prev. Close 17.16
Today's Range 16.92 - 17.20
52wk Range 3.670 - 17.57
Shares Outstanding 37,747,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Halper Sadeh LLC is Investigating Whether RLYB, KALV, INM, TMHC are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire

Performance

YTD
+203.8%
+203.8%
1 Month
+1.1%
+1.1%
3 Month
+7.9%
+7.9%
6 Month
+93.8%
+93.8%
1 Year
+258.6%
+258.6%

More News

Read More
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Taylor Morrison Home Corporation (NYSE - TMHC), Rallybio Corporation (Nasdaq – RLYB), InMed Pharmaceuticals, Inc. (Nasdaq – INM), KalVista Pharmaceuticals, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
RALLYBIO CORP (NASDAQ:RLYB) Passes Minervini Trend and High Growth Momentum Filters ↗
Via Chartmill
News headline image
RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement
From Rallybio Corporation
Via Business Wire
These stocks are moving in today's session ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Monday's session. ↗
Via Chartmill
Discover the top movers in Monday's pre-market session. ↗
Via Chartmill
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether RLYB, TALK, UNF are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rallybio Corporation (Nasdaq – RLYB), SunOpta Inc. (Nasdaq – STKL), Talkspace, Inc. (Nasdaq - TALK), Kennedy-Wilson Holdings, Inc. (Nasdaq - KW)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether TALK, JTAI, RLYB are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB
From Kahn Swick & Foti, LLC
Via Business Wire
Monday's session: top gainers and losers ↗
Via Chartmill
News headline image
RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Deal for its Shareholders
From Halper Sadeh LLC
Via Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Rallybio Corporation and Candid Therapeutics Announce Merger Agreement
From Candid Therapeutics, Inc.
Via Business Wire
News headline image
Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio Announces Reverse Stock Split of Common Stock
From Rallybio Corporation
Via Business Wire
News headline image
RALLYBIO CORP (NASDAQ:RLYB) Reports Q3 2025 Earnings Beat Fueled by Asset Sale and Advances Clinical Pipeline ↗
Via Chartmill
Topics Earnings
News headline image
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Rallybio Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Rallybio Corporation - Common Stock publicly traded?
Yes, Rallybio Corporation - Common Stock is publicly traded.
What exchange does Rallybio Corporation - Common Stock trade on?
Rallybio Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rallybio Corporation - Common Stock?
The ticker symbol for Rallybio Corporation - Common Stock is RLYB on the Nasdaq Stock Market
What is the current price of Rallybio Corporation - Common Stock?
The current price of Rallybio Corporation - Common Stock is 17.19
When was Rallybio Corporation - Common Stock last traded?
The last trade of Rallybio Corporation - Common Stock was at 09/18/26 04:00 PM ET
What is the market capitalization of Rallybio Corporation - Common Stock?
The market capitalization of Rallybio Corporation - Common Stock is 648.88M
How many shares of Rallybio Corporation - Common Stock are outstanding?
Rallybio Corporation - Common Stock has 649M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.